Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Chemo Mouthpiece

Explore full profile

The Chemo Mouthpiece introduces a novel oral cryotherapy device for managing oral mucositis therapeutically

Wilmington, United StatesFounded 2017Health Tech & Medtech
Valuation $50–100M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Chemo Mouthpiece and the history behind them.

About Chemo Mouthpiece

Chemo Mouthpiece, LLC specializes in developing an innovative cryotherapy device designed to alleviate the symptoms of chemotherapy-related oral mucositis, a painful and debilitating condition affecting cancer patients. The device, known as 'The Chemo,' is composed of medical-grade silicone, fresh water, and a proprietary saline solution. It features a dual-chamber design where the inner chamber, filled with fresh water, freezes solid, while the outer chamber, filled with saline solution, remains extremely cold without freezing solid. This design ensures uniform cooling of the entire oral cavity, making it more effective and tolerable than traditional ice chips.

The company primarily serves cancer patients undergoing chemotherapy, providing a more efficient and comfortable solution to oral mucositis. Operating in the healthcare and medical device market, Chemo Mouthpiece, LLC follows a business-to-consumer (B2C) model, selling its product directly to patients and healthcare providers. Revenue is generated through direct sales of the device and potential licensing of its patented technology.

The Chemo Mouthpiece has been recognized by leading cancer care organizations such as NCCN, MASCC, and ONS for its effectiveness in reducing oral mucositis. The company has filed for numerous patents globally, with several already granted, ensuring a strong intellectual property position.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Wilmington, United States
Employees
13
Open positions
5
Dealroom signal
45.4/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Oncology, Non-Invasive medical devices and treatments, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b, b2c

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Sep 2024 $5M $76M InfuSystem Holdings · Sanara MedTech ↗
EARLY VC✓Equity / VC Feb 2024 $10M $40M Redpoint eventures · TM3 Capital · Açolab Ventures · ArcelorMittal ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Chemo Mouthpiece website traffic

Latest recorded traffic for Chemo Mouthpiece is 6.3K monthly website visits, down 34.4% over the last three months. Chemo Mouthpiece's team grew 8.3% over the past year.

Latest monthly visits6.3K 3-month web change-34.4% 1-year team growth+8.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Redpoint eventures
  • TM3 Capital
  • Açolab Ventures
  • ArcelorMittal
  • InfuSystem Holdings
  • Sanara MedTech
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Chemo Mouthpiece on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Chemo Mouthpiece’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.